XML 35 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Reportable Segments
 6 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Reportable Segments
18. Reportable Segments:
Summarized financial information for the Company’s reportable segments is shown in the following table:
Three months ended
June 30,		Six months ended
June 30,
2020201920202019
Sales:
Refining Services$90,432  $117,290  $191,123  $223,134  
Catalysts(1)
25,208  20,857  50,072  36,723  
Performance Materials104,203  118,872  169,772  179,961  
Performance Chemicals142,641  177,828  316,920  358,290  
Eliminations(2)
(2,959) (3,172) (6,764) (7,212) 
Total$359,525  $431,675  $721,123  $790,896  
 Segment Adjusted EBITDA:(3)
Refining Services
$34,996  $42,824  $72,179  $82,555  
Catalysts(4)
25,312  29,607  47,979  47,734  
Performance Materials
27,306  29,221  40,813  39,736  
Performance Chemicals
34,011  41,165  74,485  83,838  
 Total Segment Adjusted EBITDA(5)
$121,625  $142,817  $235,456  $253,863  

(1)Excludes the Company’s proportionate share of sales from the Zeolyst International and Zeolyst C.V. joint ventures (collectively, the “Zeolyst Joint Venture”) accounted for using the equity method (see Note 11 to these condensed consolidated financial statements for further information). The proportionate share of sales is $40,852 and $39,124 for the three months ended June 30, 2020 and 2019, respectively. The proportionate share of sales is $73,143 and $68,602 for the six months ended June 30, 2020 and 2019, respectively.
(2)The Company eliminates intersegment sales when reconciling to the Company’s condensed consolidated statements of income.
(3)The Company defines Adjusted EBITDA as EBITDA adjusted for certain items as noted in the reconciliation below. Management evaluates the performance of its segments and allocates resources based on several factors, of which the primary measure is Adjusted EBITDA. Adjusted EBITDA should not be considered as an alternative to net income as an indicator of the Company’s operating performance. Adjusted EBITDA as defined by the Company may not be comparable with EBITDA or Adjusted EBITDA as defined by other companies.
(4)The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $16,855 for the three months ended June 30, 2020, which includes $11,489 of equity in net income plus $1,659 of amortization of investment in affiliate step-up and $3,707 of joint venture depreciation, amortization and interest. The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $17,636 for the three months ended June 30, 2019, which includes $12,264 of equity in net income plus $1,659 of amortization of investment in affiliate step-up and $3,713 of joint venture depreciation, amortization and interest.
The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $30,580 for the six months ended June 30, 2020, which includes $19,806 of equity in net income plus $3,317 of amortization of investment in affiliate step-up and $7,457 of joint venture depreciation, amortization and interest. The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $25,993 for the six months ended June 30, 2019, which includes $14,300 of equity in net income plus $4,217 of amortization of investment in affiliate step-up and $7,476 of joint venture depreciation, amortization and interest.
(5)Total Segment Adjusted EBITDA differs from the Company’s consolidated Adjusted EBITDA due to unallocated corporate expenses.
A reconciliation of net income attributable to PQ Group Holdings to Segment Adjusted EBITDA is as follows:
Three months ended
June 30,		Six months ended
June 30,
2020201920202019
Reconciliation of net income attributable to PQ Group Holdings Inc. to Segment Adjusted EBITDA
Net income attributable to PQ Group Holdings Inc.$15,926  $30,574  $16,150  $33,725  
Provision for income taxes16,262  20,307  17,689  22,754  
Interest expense, net22,275  28,540  46,730  57,158  
Depreciation and amortization44,822  45,090  90,493  90,984  
Segment EBITDA99,285  124,511  171,062  204,621  
Joint venture depreciation, amortization and interest3,708  3,713  7,457  7,476  
Amortization of investment in affiliate step-up1,659  1,659  3,317  4,217  
Debt extinguishment costs—  —  2,513  —  
Net (gain) loss on asset disposals(1,020) (9,653) 8,401  (8,833) 
Foreign currency exchange (gain) loss(854) 3,612  2,483  923  
LIFO expense(1,469) 122  (1,798) 10,280  
Transaction and other related costs739  975  2,801  1,055  
Equity-based compensation6,366  5,370  12,286  8,770  
Restructuring, integration and business optimization expenses3,591  (13) 5,620  719  
Defined benefit pension plan (benefit) cost(252) 552  (500) 1,545  
Other1,284  1,605  2,538  2,721  
Adjusted EBITDA113,037  132,453  216,180  233,494  
Unallocated corporate expenses8,588  10,364  19,276  20,369  
Segment Adjusted EBITDA$121,625  $142,817  $235,456  $253,863